Status | Study |
Active, not recruiting |
Study Name: Pasireotide LAR and Pegvisomant Study in Acromegaly Condition: Acromegaly Date: 2015-12-07 Interventions: Drug: Pasireotide LAR 60 mg as |
Active, not recruiting |
Study Name: Validation Study of the SAGIT® Instrument in Acromegaly Condition: Acromegaly Date: 2015-07-07 |
Completed |
Study Name: Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly Condition: Acromegaly Date: 2015-07-07 Interventions: Drug: Lanreotide Autogel® |
Recruiting |
Study Name: Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation Condition: Acromegaly Date: 2015-03-23 Interventions: Device: Fiberoptic In the event of failed intubation under direct laryngoscopy, fiberoptic intubation wi |
Active, not recruiting |
Study Name: Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. Condition: Acromegaly Date: 2015-03-18 |
Recruiting |
Study Name: Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly Condition: Acromegaly Date: 2015-03-18 Interventions: Drug: Lanreotide PRF Other Name: Lanreotide acetate |
Recruiting |
Study Name: Acromegaly & Sleep Apnoea Condition: Acromegaly Date: 2015-02-11 |
Recruiting |
Study Name: Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues Condition: Acromegaly Date: 2015-02-04 Interventions: Drug: Sandostatin (Octreotide Acetate) For the patients ou |
Active, not recruiting |
Study Name: Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues Condition: Acromegaly Date: 2015-01-29 Interventions: Drug: Pasireotide LAR Pasireotide 40 mg and 60 mg. O |
Recruiting |
Study Name: Late Effects of Radiosurgery on Acromegaly Study Condition: Acromegaly Date: 2014-10-28 Interventions: Device: Gamma Knife radiosurgery To determine potential long-term (superior to 10 years) extra-pituitary |